FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company Profile4DMedical Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
4DX.AX
4DMedical Limited Stock AnalysisComprehensive stock analysis for 4DMedical Limited (4DX.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock Analysis4DX.AX
4DX.AX
4DMedical Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
4DX.AX
  1. Home
  2. Stocks
  3. 4DMedical Limited

4DMedical Limited

🇦🇺4DX.AX•ASX

4DMedical Limited

🇦🇺4DX.AX•ASX

Your view on 4DX.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About 4DMedical Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
Andreas Fouras
Headquarters
Melbourne Connect, Carlton, VIC, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Andreas Fouras
Headquarters
Melbourne Connect, Carlton, VIC, AU
Description

Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Technology, an advanced system for four-dimensional lung imaging.

Beyond this core offering, its suite of products includes a software-as-a-service (SaaS) delivery model, specialized XV lung ventilation analysis software, and Permetium—a preclinical imaging system designed to quantify regional changes in pulmonary function. Additionally, the firm provides the AccuVent 200, a ventilator tailored for small animals.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for 4DMedical Limited. Starting points for 4DMedical Limited: EPS -AUD 0.34, beta 2.00 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for 4DMedical Limited. 4DMedical Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for 4DMedical Limited. Trailing twelve-month EPS for 4DMedical Limited stands at -AUD 0.34. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00−AUD 0.04−AUD 0.06−AUD 0.02
Lowest estimateAUD 0.00−AUD 0.04−AUD 0.08−AUD 0.04
Highest estimateAUD 0.00−AUD 0.04−AUD 0.04AUD 0.00
Number of analysts0122
A year ago−AUD 0.05−AUD 0.05−AUD 0.031—
Growth vs a year ago+100.0%+27.1%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 1.65MAUD 3.00MAUD 20.07MAUD 51.75M
Lowest estimateAUD 1.65MAUD 3.00MAUD 13.73MAUD 35.65M
Highest estimateAUD 1.65MAUD 3.00MAUD 25.78MAUD 59.94M
Number of analysts1133
A year agoAUD 232713.00AUD 2.96MAUD 7.06M—
Growth vs a year ago+610.3%+1.3%+184.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for 4DMedical Limited. 4DMedical Limited has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold 4DX.AX17 companies · 8 funds
Compare 4DX.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
M7T.AXMach7 Technologies LimitedHealthcareMedical - Healthcare Information Services—
OIL.AXOptiscan Imaging LimitedHealthcareMedical - Specialties—
PME.AXPro Medicus LimitedHealthcareMedical - Healthcare Information Services—
SHG.AXSingular Health Group LtdHealthcareMedical - Healthcare Information Services—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
CSDXCS Diagnostics Corp.HealthcareOTC$40.0M
CSSPFNIOX Group PlcHealthcareOTC$384.5M
CSX.AXCleanSpace Holdings LimitedHealthcareASX—
CTKBCytek Biosciences, Inc.HealthcareNASDAQ$774.2M
CTSOCytosorbents CorporationHealthcareNASDAQ$17.5M
CVCapsoVision, Inc.HealthcareNASDAQ$365.6M
CVRXCVRx, Inc.HealthcareNASDAQ$17.2M
CYBQFCYBERDYNE Inc.HealthcareOTC$261.5M
CYBQYCYBERDYNE Inc.HealthcareOTC$413.7M
CYC.AXCyclopharm LimitedHealthcareASX—
CYDXCYduct Diagnostics, Inc.HealthcareOTC$4.4M
DAVIDavion Healthcare PlcHealthcareNASDAQ$26.8M
ETFs holding 4DMedical Limited
TickerFundFund assets% of the fund
VXUSVanguard Total International Stock ETF$163.2B in assets0.00%
VEAVanguard FTSE Developed Markets ETF$231.6B in assets0.00%
IEFAiShares Core MSCI EAFE ETF$188.8B in assets0.00%
SCZiShares MSCI EAFE Small-Cap ETF$12.6B in assets0.02%
HEALGlobal X - HealthTech ETF$38M in assets1.01%
GWXState Street SPDR S&P International Small Cap ETF$882M in assets0.06%
IPACiShares Core MSCI Pacific ETF$2.6B in assets0.01%
VPLVanguard FTSE Pacific ETF$9.0B in assets0.01%

Largest holders first, then the funds most concentrated in 4DX.AX.

Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for 4DMedical Limited. Coverage tracks 4DMedical Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of 4DMedical Limited.

4DX.AX AnalysisGood
Past
5
Growth
5
Health
5
Profit
1
Value
1